Alpha Tau Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-29.16	-33.76	-27.27	-8.88	-8.37
Depreciation & Amortization	1.07	0.98	0.78	0.09	0.07
Share-Based Compensation	7.93	6.75	0.81	0.6	0.55
Other Operating Activities	2.2	2.16	13.87	0.95	0.85
Operating Cash Flow	-17.96	-23.88	-11.81	-7.25	-6.91
Capital Expenditures	-6.4	-0.9	-2.93	-3.77	-1.29
Change in Investments	25.08	-89.03	22.2	-4.05	-8.87
Investing Cash Flow	18.68	-89.94	19.27	-7.82	-10.16
Share Issuance / Repurchase	0.05	96.91	0.11	0.59	6.27
Debt Issued / Paid	5.25	0	0	0	0
Other Financing Activities	-	-	-	28.73	-0.95
Financing Cash Flow	5.3	96.91	0.11	29.32	5.32
Exchange Rate Effect	-0.05	-0.26	0.11	0.08	-0.02
Net Cash Flow	5.97	-17.17	7.68	14.33	-11.77
Free Cash Flow	-24.36	-24.78	-14.74	-11.02	-8.2
Free Cash Flow Per Share	-0.35	-0.39	-0.36	-0.27	-0.24

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).